1. "Sarcoma Service"
Formats
  1. Journal Article (444)
  2. Meeting Abstract (429)
  3. Review (26)
  4. Editorial (8)
  5. Guidelines (8)
  6. Book Section (6)
  7. Miscellaneous (6)
  8. Research Letter (6)
  9. Correspondence (2)
  10. Book Whole (1)
Groups
  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)

More Groups

People
  1. William Tap (372)
  2. Sandra D'Angelo (252)
  3. Mrinal Gounder (228)
  4. Ping Chi (172)
  5. Mark Dickson (169)
  6. Cristina Antonescu (135)

More People

Years
  1. 2025 (27)
  2. 2024 (87)
  3. 2023 (79)
  4. 2022 (116)
  5. 2021 (76)
  6. 2020 (90)

More Years

Publications
  1. Journal of Clinical Oncology (272)
  2. Annals of Oncology (70)
  3. Clinical Cancer Research (60)
  4. Cancer Research (31)
  5. Journal for ImmunoTherapy of Cancer (25)
  6. Cancer (19)

More Publications

Publishers
  1. American Society of Clinical Oncology (286)
  2. American Association for Cancer Research (107)
  3. Oxford University Press (91)
  4. Elsevier Inc. (59)
  5. Nature Publishing Group (41)
  6. Springer (40)

More Publishers

Results (936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mutation profile of drug resistant gastrointestinal stromal tumor (GIST) patients (pts) enrolled in the phase 1 study of DCC-2618
    Meeting Abstract

    George, S.; Heinrich, M. C.; Razak, A. R. A.; Chi, P.; Gordon, M. S.; Ganjoo, K. N.; von Mehren, M.; Somaiah, N.; Trent, J. C.; Su, Y.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Predicting overall survival in patients (pts) with treatment-naive metastatic Merkel cell carcinoma (mMCC) treated with avelumab
    Meeting Abstract

    Bullement, A.; D'Angelo, S. P.; Amin, A.; Stapelkamp, C.; Willis, A.; Lilley, C.; Hatswell, A.; Bharmal, M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • ADAM trial: A multicenter, randomized, double-blinded, placebo-controlled, phase 3 trial of adjuvant avelumab (anti-PD-L1 antibody) in merkel cell carcinoma patients with clinically detected lymph node metastases; NCT03271372
    Meeting Abstract

    Bhatia, S.; Brohl, A. S.; Brownell, I.; Chandra, S.; Dakhil, S.; Ernstoff, M. S.; Fecher, L. A.; Gooley, T.; Hanna, G. J.; Hibbert, R.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 1 study of MDM2 inhibitor DS-3032b in patients with well/de-differentiated liposarcoma (WD/DD LPS), solid tumors (ST) and lymphomas (L)
    Meeting Abstract

    Bauer, T. M.; Gounder, M. M.; Weise, A. M.; Schwartz, G. K.; Carvajal, R. D.; Kumar, P.; Zernovak, O.; Beck, A.; Doyle, J.; Mendell-Harary, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Immune checkpoint inhibitors in sarcoma
    Book Section

    D'Angelo, S. P.; Kelly, C. M.
    In D'Angelo, S. P.; Pollack, S. M. (Eds.) Immunotherapy of Sarcoma (2018)

    Fulltext@MSK | Save
  • Pharmacokinetic (PK), safety, and tolerability profile of DCC-2618 in a phase I trial supports 150mg QD selected for a pivotal phase III trial in gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Janku, F.; Heinrich, M.; Razak, A.; Gordon, M.; Chi, P.; Ganjoo, K.; von Mehren, M.; Somaiah, N.; Lee, J.; Kuida, K.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    Ran, L.; Chen, Y.; Wong, W. P. E.; Li, D.; Cao, Z.; Shukla, S.; Xie, Y.; Zheng, D.; Koche, R. P.; Antonescu, C. R.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Clinical neurological features and electrographic patterns of patients with relapsed or refractory large B-cell lymphoma treated with axicabtagene ciloleucel at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Sequeira, A.; Mao, D.; Chen, X.; Avila, E.; Mead, E.; Sauter, C. S.; Palomba, M. L.; Dahi, P. B.; Batlevi, C. L.; Shah, G.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults: Epithelioid sarcoma cohort (NCT02601950)
    Meeting Abstract

    Gounder, M.; Schöffski, P.; Villalobos, V.; Cote, G.; Chugh, R.; Chen, T. W. W.; Jahan, T.; Loggers, E. T.; Italiano, A.; Gupta, A.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Correlation of ctDNA and response in patients (pts) with PDGFRα D842 GIST treated with avapritinib
    Meeting Abstract

    George, S.; Bauer, S.; Jones, R. L.; Serrano, C.; von Mehren, M.; Kang, Y. K.; Schöffski, P.; Cassier, P.; Eskens, F. A.; Mir, O.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save